ArticleFrontiers in artificial intelligence2025
XAI-MRI: an ensemble dual-modality approach for 3D brain tumor segmentation using magnetic resonance imaging.
Article in Frontiers in artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Impact of MRI modality selection on glioma sub-region segmentation using 3D U-Net and Attention U-Net: A comparative evaluation across ten MRI sequences.European journal of radiology open · 2026Article
- A Robust ConvNeXt-Based Framework for Efficient, Generalizable, and Explainable Brain Tumor Classification on MRI.Bioengineering (Basel, Switzerland) · 2026Article
- Global-local feature fusion: a robust hybrid deep learning model for multiclass brain tumor classification with Grad-CAM++ interpretation.Frontiers in genetics · 2026Article
- Bridging global context and local precision using a disagreement-based region specific ensemble of Swin UNETR and SegResNet for 3D glioma segmentation.Frontiers in artificial intelligence · 2026Article
- HyRA-CXR: a hybrid residual-attention deep network for chest X-ray classification.Frontiers in artificial intelligence · 2026Article
- Brain tumor segmentation using deep learning: high performance with minimized MRI data.Frontiers in radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Brain tumor segmentation from Magnetic Resonance Images (MRI) presents significant challenges due to the complex nature of brain tumor tissues. This complexity poses a significant challenge in distinguishing tumor tissues from healthy tissues, particularly when radiologists rely on manual segmentation. Reliable and accurate segmentation is crucial for effective tumor grading and treatment planning. In this paper, we proposed a novel ensemble dual-modality approach for 3D brain tumor segmentation using MRI. Initially, individual U-Net models are trained and evaluated on single MRI modalities (T1, T2, T1ce, and FLAIR) to establish each modality's performance. Subsequently, we trained U-net models using combinations of the best-performing modalities to exploit the complementary information and improve segmentation accuracy. Finally, we introduced the ensemble dual-modality by combining the two best-performing pre-trained dual-modalities models to enhance segmentation performance. Experimental results show that the proposed model enhanced the segmentation result and achieved a Dice Coefficient of 97.73% and a Mean IoU of 60.08%. The results illustrate that the ensemble dual-modality approach outperforms single-modality and dual-modality models. Grad-CAM visualizations are implemented, generating heat maps that highlight tumor regions and provide useful information to clinicians about how the model made the decision, increasing their confidence in using deep learning-based systems. Our code publicly available at: https://github.com/Ahmeed-Suliman-Farhan/Ensemble-Dual-Modality-Approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.